The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC).
 
Filippo Pietrantonio
Honoraria - Amgen; AstraZeneca/MedImmune; Bayer; Lilly; MSD Oncology; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; SERVIER
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Alessandra Raimondi
Speakers' Bureau - Elma Academy; SERVIER
Travel, Accommodations, Expenses - Amgen
 
Sara Lonardi
No Relationships to Disclose
 
Sabina Murgioni
No Relationships to Disclose
 
Giovanni Gerardo Cardellino
No Relationships to Disclose
 
Stefano Tamberi
No Relationships to Disclose
 
Antonia Strippoli
No Relationships to Disclose
 
Federica Palermo
No Relationships to Disclose
 
Michele Prisciandaro
No Relationships to Disclose
 
Giovanni Randon
No Relationships to Disclose
 
Francesca Corti
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen
 
Francesca Bergamo
No Relationships to Disclose
 
Floriana Nappo
No Relationships to Disclose
 
Alberto Giovanni Leone
No Relationships to Disclose
 
Giuseppe Leoncini
No Relationships to Disclose
 
Giovanna Sabella
No Relationships to Disclose
 
Kristiyana Kaneva
Employment - Tempus
Stock and Other Ownership Interests - Tempus
Travel, Accommodations, Expenses - Tempus
 
Carlo Sposito
No Relationships to Disclose
 
Maria Di Bartolomeo
Honoraria - BMSi; Lilly; MSD Oncology; SERVIER
Consulting or Advisory Role - Lilly; MSD Oncology
Research Funding - Lilly (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Astra Zeneca
 
Vincenzo Mazzaferro
No Relationships to Disclose